Name: ALNY Income Statement - Alnylam Pharmaceuticals Revenue & EPS | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Revenue, Cost of Revenue, Gross Profit, Operating Expenses, Operating Income, Net Income, EPS Basic, EPS Diluted

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

ALNY - Alnylam Pharmaceuticals, Inc.

USD | NASDAQ | Healthcare

ALNY Income Statement - Alnylam Pharmaceuticals Revenue & EPS | Ledgeburg

(in millions of USD, except per-share data)	Q4 FY 25	Q3 FY 25	Q2 FY 25	Q1 FY 25	Q4 FY 24	Q3 FY 24	Q2 FY 24	Q1 FY 24	Q4 FY 23	Q3 FY 23	Q2 FY 23	Q1 FY 23	Q4 FY 22	Q3 FY 22	Q2 FY 22	Q1 FY 22	Q4 FY 21	Q3 FY 21	Q2 FY 21	Q1 FY 21	Q4 FY 20	Q3 FY 20	Q2 FY 20	Q1 FY 20	Q4 FY 19	Q3 FY 19	Q2 FY 19	Q1 FY 19	Q4 FY 18	Q3 FY 18	Q2 FY 18	Q1 FY 18	Q4 FY 17	Q3 FY 17	Q2 FY 17	Q1 FY 17	Q4 FY 16	Q3 FY 16	Q2 FY 16	Q1 FY 16
Revenues
Revenues	1,097.0	1,249.0	773.7	594.2	593.2	500.9	659.8	494.3	439.7	750.5	318.8	319.3	335.0	264.3	224.8	213.3

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

(in millions of USD, except per-share data)	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015	FY2014	FY2013	FY2012	FY2011	FY2010	FY2009	FY2008
Revenues
Revenues	3,713.9	2,248.2	1,828.3	1,037.4	844.3	492.9	219.8	74.9	89.9	47.2	-	-	-	-	-	100.0	100.5	96.2
Cost of Revenue	677.2	306.5	268.2	140.2	115.0	74.2	25.1	1.8	0.0	-	-	-	-	-	-	-	-	-
Gross Profit	3,036.8	1,941.7	1,560.1	897.2	729.3	418.7	194.7	73.1	89.9	-	-	-	-	-	-	-	-
Operating Expenses
Research & Development	1,319.8	1,126.2	1,004.4	883.0	792.2	654.8	655.1	505.4	390.6	382.4	276.5	190.2	113.0	86.6	99.3
Operating Income
Operating Income	501.6	(176.9)	(282.2)	(785.1)	(708.7)	(828.4)	(939.4)	(814.7)	(500.1)	(424.6)	(296.0)	(405.0)	(92.9)	(129.5)
Non-Operating
Interest Income	111.5	122.0	95.6	24.8	1.6	11.8	33.4	29.3	-	-	-	-	-	1.0	1.2	2.3
Tax & Net
Income Tax Expense	9.4	(99.2)	6.7	4.2	0.7	2.7	0.9	0.8	0.0	0.0	0.0	(40.2)	(2.7)	(10.6)	0.0
Per Share
EPS Basic	2.39	(2.18)	(3.52)	(9.30)	(7.20)	(7.46)	(8.11)	-	-	-	-	-	-	-	-	-
Supplementary Data
EBITDA	556.4	(121.8)	(230.6)	(746.0)	(671.9)	(798.2)	(922.8)	(801.9)	(486.7)	(409.5)	(277.0)	(393.1)	(82.7)	(120.4)	(49.7)	(39.1)

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

Operating Expenses
Research & Development	372.2	358.8	323.6	265.1	300.2	270.9	294.1	261.0	272.1	253.2	248.5	230.6	262.0	245.4	205.7	169.9	229.1	194.6	182.6	185.9	168.5	161.8	155.0	169.6	201.3	160.8	163.9	129.1	131.0	139.9	137.6	96.9	117.8	95.3	90.6	87.0	105.0	97.9	83.2	96.3
Selling General & Administrative	325.4	322.1	323.3	239.9	295.3	221.0	248.4	210.8	198.1	199.2	214.7	183.7	210.3	235.9	170.0	154.5
Selling & Marketing	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General & Administrative	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Depreciation & Amortization	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Amortization of Intangibles	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Operating Expenses	965.3	881.0	789.9	576.1	698.3	577.8	611.2	537.8	556.1	536.7	548.6	469.1	523.6	522.3	416.5	360.0

Operating Income
Operating Income	131.7	368.0	(16.2)	18.1	(105.2)	(76.9)	48.6	(43.4)	(116.4)	213.9	(229.8)	(149.8)	(188.6)	(258.0)	(191.7)	(146.7)	(194.6)	(181.7)	(146.2)	(186.3)	(194.2)	(225.2)	(198.9)	(210.2)	(298.1)	(216.3)	(236.3)	(188.8)	(220.4)	(254.6)	(192.4)	(147.4)	(147.3)	(125.8)	(120.5)	(106.5)	(115.4)	(106.7)	(92.5)	(110.0)

Non-Operating
Interest Income	26.6	28.7	27.5	28.7	31.0	32.1	29.2	29.6	30.4	25.4	21.1	18.7	14.1	7.8	1.9	1.0	0.5	0.2	0.4	0.5	1.1	2.1	3.2	5.5	-	9.9	8.8	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	129.3	44.4	40.2	38.6	39.0	34.4	33.3	35.3	31.3	30.9	30.0	29.0	29.9	41.1	42.6	42.4	36.8	40.3
Income From Equity Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Non-Operating Income	29.4	(129.0)	(19.2)	(59.7)	(88.8)	(31.8)	(59.8)	(20.2)	(21.3)	(63.1)	(44.4)	(22.6)	(18.4)	(147.9)	(83.0)	(92.6)
Pre-Tax Income	161.1	239.0	(35.4)	(41.6)	(194.0)	(108.7)	(11.2)	(63.6)	(137.7)	150.7	(274.2)	(172.4)	(207.0)	(405.9)	(274.7)	(239.4)

Tax & Net
Income Tax Expense	(25.3)	(12.1)	30.9	15.9	(110.2)	2.9	5.7	2.3	0.2	3.0	1.8	1.7	0.5	(0.0)	2.7	1.0	(1.8)	0.3	1.2	1.0	(0.1)	0.8	1.3	0.6	(0.4)	(0.4)	1.0	0.7	0.4	0.4	0.1	(0.1)	-	-	-	-	-	-	-	-
Net Income From Continuing Ops	186.4	251.1	(66.3)	(57.5)	(83.8)	(111.6)	(16.9)	(65.9)	(137.9)	147.8	(276.0)	(174.1)	(207.5)	(405.9)	(277.4)	(240.3)	(258.5)
Net Income From Discontinued Ops	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	186.4	251.1	(66.3)	(57.5)	(83.8)	(111.6)	(16.9)	(65.9)	(137.9)	147.8	(276.0)	(174.1)	(207.5)	(405.9)	(277.4)	(240.3)	(258.5)
Net Income Attributable To Parent	186.4	251.1	(66.3)	(57.5)	(83.8)	(111.6)	(16.9)	(65.9)	(137.9)	147.8	(276.0)	(174.1)	(207.5)	(405.9)	(277.4)	(240.3)
Less: Minority Interest	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Less: Preferred Dividends	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income To Common Shareholders	186.4	251.1	(66.3)	(57.5)	(83.8)	(111.6)	(16.9)	(65.9)	(137.9)	147.8	(276.0)	(174.1)	(207.5)	(405.9)	(277.4)

Per Share
EPS Basic	-	1.91	(0.51)	(0.44)	-	(0.87)	(0.13)	(0.52)	-	1.18	(2.21)	(1.40)	-	(3.32)	(2.29)	(2.00)	-	(1.72)	(1.61)	(1.71)	-	(2.18)	(1.56)	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EPS Diluted	-	1.84	(0.51)	(0.44)	-	(0.87)	(0.13)	(0.52)	-	1.15	(2.21)	(1.40)	-	(3.32)	(2.29)	(2.00)	-	(1.72)
Shares Basic	-	131.4	130.6	129.7	-	128.6	126.7	126.1	-	125.2	124.7	124.1	-	122.2	120.9	120.4	-	119.1
Shares Diluted	-	137.3	130.6	129.7	-	128.6	126.7	126.1	-	131.3	124.7	124.1	-	122.2	120.9	120.4	-	119.1

Supplementary Data
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	(144.2)	-	-	-	(103.5)	-	-	-	(105.4)
EBIT	131.7	368.0	(16.2)	18.1	(105.2)	(76.9)	48.6	(43.4)	(116.4)	213.9	(229.8)	(149.8)	(188.6)	(258.0)	(191.7)	(146.7)	(194.6)	(181.7)	(146.2)